Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.8 EUR
130.59 M EUR
1.11 B EUR
44.25 M
About KOBAYASHI PHARMACEUTICALS
Sector
Headquarters
Osaka
Founded
1886
Website
ISIN
JP3301100008
FIGI
BBG000CBWSV0
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic Business and International Business. The Domestic Business segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International Business segment sells beauty and health care products overseas. . The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange KOBAYASHI PHARMACEUT. stocks are traded under the ticker KOY.
We've gathered analysts' opinions on KOBAYASHI PHARMACEUT. future price: according to them, KOY price has a max estimate of 43.19 EUR and a min estimate of 30.23 EUR. Watch KOY chart and read a more detailed KOBAYASHI PHARMACEUT. stock forecast: see what analysts think of KOBAYASHI PHARMACEUT. and suggest that you do with its stocks.
Yes, you can track KOBAYASHI PHARMACEUT. financials in yearly and quarterly reports right on TradingView.
KOBAYASHI PHARMACEUT. is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
KOY earnings for the last quarter are 0.33 EUR per share, whereas the estimation was 0.51 EUR resulting in a −36.16% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about KOBAYASHI PHARMACEUT. earnings.
KOBAYASHI PHARMACEUT. revenue for the last quarter amounts to 258.20 M EUR, despite the estimated figure of 273.96 M EUR. In the next quarter, revenue is expected to reach 318.40 M EUR.
KOY net income for the last quarter is 24.42 M EUR, while the quarter before that showed 2.67 M EUR of net income which accounts for 815.55% change. Track more KOBAYASHI PHARMACEUT. financial stats to get the full picture.
KOBAYASHI PHARMACEUT. dividend yield was 1.49% in 2023, and payout ratio reached 37.66%. The year before the numbers were 1.00% and 34.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 3.53 K employees. See our rating of the largest employees — is KOBAYASHI PHARMACEUT. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOBAYASHI PHARMACEUT. EBITDA is 194.07 M EUR, and current EBITDA margin is 18.36%. See more stats in KOBAYASHI PHARMACEUT. financial statements.
Like other stocks, KOY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOBAYASHI PHARMACEUT. stock right from TradingView charts — choose your broker and connect to your account.